Katsuhiko Tomibe

Title: Innovations of Katsuhiko Tomibe

Introduction

Katsuhiko Tomibe is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies for diagnosing and treating infections caused by Pseudomonas aeruginosa. With a total of 3 patents, his work has the potential to impact medical diagnostics and therapies.

Latest Patents

Tomibe's latest patents include the E87Ag antigens of Pseudomonas aeruginosa and monoclonal antibodies targeting this specific antigen. His innovations encompass a P. aeruginosa E87Ag antigen that comprises a polysaccharide fraction with a molecular weight of about 27,000, which is contained in the lipopolysaccharide of P. aeruginosa. Additionally, he has developed an anti-P. aeruginosa human or mouse monoclonal antibody that recognizes the E87Ag antigen. Furthermore, he has created a mouse-human or mouse-mouse hybridoma that produces this monoclonal antibody. These advancements can be utilized for the diagnosis and therapy of infections caused by P. aeruginosa.

Career Highlights

Katsuhiko Tomibe is currently associated with Teijin Limited, where he continues to innovate in the field of biomedical research. His work has garnered attention for its potential applications in healthcare, particularly in combating bacterial infections.

Collaborations

Tomibe has collaborated with esteemed colleagues such as Yasuhiko Masuho and Kimihiko Matsuzawa. Their combined expertise contributes to the advancement of research and development in their respective fields.

Conclusion

Katsuhiko Tomibe's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work on monoclonal antibodies for Pseudomonas aeruginosa showcases the importance of innovation in addressing medical challenges.